CDKN2A and neoplasm: Therefore, although a choice of chemotherapy regimens may impact the magnitude of chemotherapy-induced increase in p16INK4a expression, an increase in p16INK4a expression is likely driven by the baseline p16INK4a expression and not chronological age or other patient and tumor characteristics.